Literature DB >> 16256213

Mice over-expressing the 5-HT(1A) receptor in cortex and dentate gyrus display exaggerated locomotor and hypothermic response to 8-OH-DPAT.

Bettina Bert1, Heidrun Fink, Heide Hörtnagl, Rüdiger W Veh, Ben Davies, Franz Theuring, Heike Kusserow.   

Abstract

The serotonin 1A (5-HT(1A)) receptor is one of the best described receptor subtypes of the serotonergic system. Due to the complex distribution pattern, the pre- and postsynaptic localisation, the impact on various monoamines, as well as the influence on a wide range of physiological functions, the contribution of 5-HT(1A) receptors to behavioural outcomes is difficult to define. In this study, we present a new transgenic mouse model with a prominent over-expression of the 5-HT(1A) receptor in the outer cortical layers (I-III) and the dentate gyrus. Behavioural studies revealed a slight decrease in baseline motor activity of homozygous mice during the open field test. Moreover, core body temperature of male transgenic mice was significantly lower than that of wild-type mice. Pharmacological studies with the 5-HT(1A) receptor agonist 8-OH-DPAT (0.1-2.5 mg/kg, i.p.) revealed an exaggerated drug response in mutant mice. 8-OH-DPAT led to a drastic decrease in motor activity in the open field and elevated plus maze test. This significant effect on motor activity became more apparent by investigating the serotonergic syndrome induced by 8-OH-DPAT. Concentration as low as 0.5 mg/kg 8-OH-DPAT caused immobility in transgenic mice for 30 min, head weaving behaviour, and backward walking, whereas in wild-type animals, typical behaviours of the serotonin syndrome were first observed at concentrations of 1.5 mg/kg and more. In addition, the 8-OH-DPAT induced hypothermia was more pronounced in mutant mice than in wild-type animals. Therefore, these genetically modified mice represent a promising model for further investigations of the role of 5-HT(1A) receptors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16256213     DOI: 10.1016/j.bbr.2005.09.020

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  14 in total

1.  Key role of the 5-HT1A receptor addressing protein Yif1B in serotonin neurotransmission and SSRI treatment.

Authors:  Vincent Martin; Lionel Mathieu; Jorge Diaz; Haysam Salman; Jeanine Alterio; Caroline Chevarin; Laurence Lanfumey; Michel Hamon; Mark C Austin; Michèle Darmon; Craig A Stockmeier; Justine Masson
Journal:  J Psychiatry Neurosci       Date:  2020-09-01       Impact factor: 6.186

2.  Serotonin-1A autoreceptors are necessary and sufficient for the normal formation of circuits underlying innate anxiety.

Authors:  Jesse W Richardson-Jones; Caryne P Craige; Thanh H Nguyen; Hank F Kung; Alain M Gardier; Alex Dranovsky; Denis J David; Bruno P Guiard; Sheryl G Beck; René Hen; E David Leonardo
Journal:  J Neurosci       Date:  2011-04-20       Impact factor: 6.167

3.  Effects of repeated treatment with the 5-HT1A and 5-HT1B agonists (R)-( +)-8-hydroxy-DPAT and CP-94253 on the locomotor activity and axillary temperatures of preweanling rats: evidence of tolerance and behavioral sensitization.

Authors:  Sanders A McDougall; Jordan A Taylor; Matthew J Roe; Constance J Greenwood
Journal:  Psychopharmacology (Berl)       Date:  2021-11-24       Impact factor: 4.530

4.  Neuronal ablation of p-Akt at Ser473 leads to altered 5-HT1A/2A receptor function.

Authors:  Jeremy M Veenstra-Vanderweele; Aurelio Galli; Christine Saunders; Michael Siuta; Sabrina D Robertson; Adeola R Davis; Jennifer Sauer; Heinrich J G Matthies; Paul J Gresch; David Airey; Craig W Lindsley; John A Schetz; Kevin D Niswender
Journal:  Neurochem Int       Date:  2013-09-30       Impact factor: 3.921

5.  Differential behavioral syndrome evoked in the rats after multiple doses of SSRI fluoxetine with selective MAO inhibitors rasagiline or selegiline.

Authors:  Z Speiser; T Fine; L Litinetsky; S Eliash; E Blaugrund; S Cohen
Journal:  J Neural Transm (Vienna)       Date:  2007-09-07       Impact factor: 3.575

6.  Direct and indirect 5-HT receptor agonists produce gender-specific effects on locomotor and vertical activities in C57 BL/6J mice.

Authors:  Bethany R Brookshire; Sara R Jones
Journal:  Pharmacol Biochem Behav       Date:  2009-08-19       Impact factor: 3.533

7.  Differential effects of early environmental enrichment on emotionality related behaviours in Huntington's disease transgenic mice.

Authors:  Thibault Renoir; Terence Y C Pang; Christina Mo; Grace Chan; Caroline Chevarin; Laurence Lanfumey; Anthony J Hannan
Journal:  J Physiol       Date:  2012-10-08       Impact factor: 5.182

Review 8.  Rethinking 5-HT1A receptors: emerging modes of inhibitory feedback of relevance to emotion-related behavior.

Authors:  Stefanie C Altieri; Alvaro L Garcia-Garcia; E David Leonardo; Anne M Andrews
Journal:  ACS Chem Neurosci       Date:  2012-12-20       Impact factor: 4.418

9.  The role of the dorsal raphe nucleus in the development, expression, and treatment of L-dopa-induced dyskinesia in hemiparkinsonian rats.

Authors:  Karen L Eskow; Kristin B Dupre; Christopher J Barnum; Sando O Dickinson; John Y Park; Christopher Bishop
Journal:  Synapse       Date:  2009-07       Impact factor: 2.562

10.  Sexually dimorphic serotonergic dysfunction in a mouse model of Huntington's disease and depression.

Authors:  Thibault Renoir; Michelle S Zajac; Xin Du; Terence Y Pang; Leah Leang; Caroline Chevarin; Laurence Lanfumey; Anthony J Hannan
Journal:  PLoS One       Date:  2011-07-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.